ctrl K

AI Score

Unlock

ZyVersa Therapeutics Inc. (ZVSA)

AI Score

Unlock

1.12

-0.05 (-4.27%)

At close: Feb 28, 2025, 3:59 PM

1.13

0.89%

After-hours: Feb 28, 2025, 04:00 PM EST

ZyVersa Therapeutics Income Statement

Table Mode

Year	FY23	FY22	FY21	FY20
Revenue	n/a	n/a	n/a	n/a
Cost of Revenue	10.4K	10.4K	10.4K	10.4K
Gross Profit	-10.4K	-10.4K	-10.4K	-10.4K
Operating Income	-14.42M	-13.01M	-7.7M	-11.83M
Interest Income	n/a	427.54	821.37	516.45
Pretax Income	-107.75M	-14.05M	-8.08M	-12.68M
Net Income	-98.3M	-759.1M	-8.91M	-13.2M
Selling & General & Admin	11.2M	7.61M	5.58M	5.36M
Research & Development	3.21M	5.41M	2.12M	6.47M
Other Expenses	n/a	n/a	n/a	n/a
Operating Expenses	14.41M	13.01M	7.7M	11.83M
Interest Expense	-457K	427.54K	821.37K	516.45K
Selling & Marketing Expenses	-11.2B	n/a	n/a	n/a
Cost & Expenses	14.42M	13.01M	7.7M	11.83M
Income Tax	-9.46M	745.05M	821.37K	516.45K
Shares Outstanding (Basic)	97.5K	25.95K	46.55K	46.55K
Shares Outstanding (Diluted)	97.5K	25.95K	46.55K	46.55K
EPS (Basic)	-1.09K	-930.25	-173.66	-272.45
EPS (Diluted)	-1.09K	-930.25	-173.66	-272.45
EBITDA	-107.74M	-11.67M	-7.25M	-12.16M
Depreciation & Amortization	10.4K	10.4K	10.4K	10.4K